V.V. Rachkovskaya

V.V. Rachkovskaya

Auto-generated profile, based on publicly available information

V.V. Rachkovskaya

ArsMedica LLC

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in Siberian Medical Review
Verified
Journal Article
Closed access
IUI. Kant Baltic Federal University
I. Kant Baltic Federal University
VRV.V. Rachkovskaya
V.V. Rachkovskaya
AGA.P. Gorbunov
A.P. Gorbunov
APA.I. Pashov
A.I. Pashov
LVL.V. Volkova
L.V. Volkova

1 January 2021 in Siberian Medical Review
Verified
Journal Article
Open access
IUImmanuel Kant Baltic Federal University
Immanuel Kant Baltic Federal University
VRV.V. Rachkovskaya
V.V. Rachkovskaya
AGA.P. Gorbunov
A.P. Gorbunov
VAVeronika Anohova
Veronika Anohova
APA.I. Pashov
A.I. Pashov
VGV.E. Golikov
V.E. Golikov
Aetiological and pathogenetic aspects in uterine cervix pathology associated with persistent viral infection by the high-risk human papillomavirus (HR HPV) are considered in this scientific review. The article provides a concise description of the biological structure and life processes of the virus. The main stages of uterine cervix impairment by the viral agent crucial for cancer development are described. Additionally, some mechanisms in the escape of viral progression from the immune control are given insight into. It is considered that, alongside with the aggression of the virus toward the host cells, there is a decline of cellular and humoral immunity in the female’s genitourinary tract, which may determine the growth and development of the neoplasm as well. The article puts a large emphasis on the defensive mechanisms appearing in the female organism as a response to the invasion and the persistence of the human papillomavirus. It is assumed that complete knowledge of pathogenetic mechanisms in development of oncogenic potential of the virus would imply the absence of rampant CIN and cervical cancer development induced by invasion of the agent into the organism

11 August 2025 in Russian Bulletin of Obstetrician-Gynecologist
Verified
Journal Article
Closed access
APA.I. Pashov
A.I. Pashov
DMD.D. Matsakova
D.D. Matsakova
LVLarisa Vladimirovna Volkova
Larisa Vladimirovna Volkova
VRV.V. Rachkovskaya
V.V. Rachkovskaya
ATA.S. Turdieva
A.S. Turdieva
This article raises current issues of the use of gonadotropin-releasing hormone (GnRH) in women suffering from hyperplastic conditions in gynecology. Such diseases include: uterine fibroids, endometriosis, endometrial hyperplasia, and endometrial cancer. The article pays special attention to the pathophysiological aspects of the action of this hormone, reveals its positive pharmacological properties, as well as negative, undesirable properties (side effects). Some etiopathogenetic aspects of the development of hyperplastic diseases in gynecology and the points of influence of GnRH on them are touched upon. This article examines the general principles of pharmacological treatment of hyperplastic processes with GnRH, and also compares it with other drugs: the advantages and disadvantages of treatment methods are described.